Annovis Bio Inc. [AMEX: ANVS] closed the trading session at $5.64 on 06/16/20. The day’s price range saw the stock hit a low of $4.57, while the highest price level was $6.14. The stocks have a year to date performance of -41.19 percent and weekly performance of 5.42 percent. The stock has performed 57.98 percent around the most recent 30 days and changed 76.25 percent over the most recent 3-months.
If compared to the average trading volume of 36.52K shares, ANVS reached to a volume of 2020280 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Annovis Bio Inc. [ANVS]:
The Average True Range (ATR) for Annovis Bio Inc. is set at 0.59 The Price to Book ratio for the last quarter was 2.43, with the Price to Cash per share for the same quarter was set at 1.64.
ANVS stock trade performance evaluation
Annovis Bio Inc. [ANVS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.42.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ANVS stock in for the last two-week period is set at 65.64, with the RSI for the last a single of trading hit 67.98, and the three-weeks RSI is set at 61.89 for Annovis Bio Inc. [ANVS]. The present Moving Average for the last 50 days of trading for this stock 4.05, while it was recorded at 4.79 for the last single week of trading.
Annovis Bio Inc. [ANVS]: An insightful look at the core fundamentals
Reflecting on the efficiency of the workforce at the company, Annovis Bio Inc. [ANVS] managed to generate an average of -$495,490 per employee.Annovis Bio Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 15.30 and a Current Ratio set at 15.30.
Annovis Bio Inc. [ANVS]: Insider Ownership positions
There are presently around $1 million, or 10.30% of ANVS stock, in the hands of institutional investors. The top three institutional holders of ANVS stocks are: WORTH VENTURE PARTNERS, LLC with ownership of 143,750, which is approximately New of the company’s market cap and around 37.70% of the total institutional ownership; ZEKE CAPITAL ADVISORS, LLC, holding 27,594 shares of the stock with an approximate value of $0.12 million in ANVS stocks shares; and CANNELL PETER B & CO INC, currently with $45000.0 in ANVS stock with ownership of nearly New of the company’s market capitalization.
7 institutional holders increased their position in Annovis Bio Inc. [AMEX:ANVS] by around 193,186 shares. Additionally, 0 investors decreased positions by around 0 shares, while 0 investors held positions by with 0 shares. The mentioned changes placed institutional holdings at 193,186 shares, according to the latest SEC report filing. ANVS stock had 7 new institutional investments in for a total of 193,186 shares, while 0 institutional investors sold positions of 0 shares during the same period.